Archive for the ‘uk retractions’ Category
Research papers containing abstracts that are shorter and consist of more commonly used words accumulate citations more successfully, according to a recent study published in the Journal of Informetrics.
After analyzing more than 200,000 academic papers published between 1999 and 2008, the authors found that abstracts were slightly less likely to be cited than those that were half as long. Keeping it simple also mattered— abstracts that were heavy on familiar words such as “higher,” “increased” and “time” earned a bit more citations than others. Even adding a five-letter word to an abstract reduced citation counts by 0.02%.
Gemina Doolub admitted that she fabricated research data and submitted papers without the knowledge of her co-authors, including faking an email address for a co-author, a news story in the BMJ reports. The research in question was part of two retractions that Doolub received in 2013, one of which we covered at the time.
Doolub’s research examined ways to treat and avoid microvascular obstruction — that is, blocked arteries. Doolub did the work while at Oxford.
“Intracoronary Adenosine versus Intravenous Adenosine during Primary PCI for ST-Elevation Myocardial Infarction: Which One Offers Better Outcomes in terms of Microvascular Obstruction?” was published in International Scholarly Research Notices Cardiology and has not yet been cited, according to Thomson Reuters Web of Science.
As the BMJ reports, in that paper,
A psychology journal is retracting a 2015 paper that attracted press coverage by suggesting women’s hormone levels drive their desire to be attractive, after a colleague alerted the last author to flaws in the statistical analysis.
The paper, published online in November, found women prefer to wear makeup when there is more testosterone present in their saliva. The findings were picked up by various media including Psychology Today (“Feeling hormonal? Slap on the makeup”), and even made it onto reddit.com.
However, upon discovering a problem in the analysis of the data, the authors realized that central finding didn’t hold up, according to Psychological Science‘s interim editor, Stephen Lindsay: Read the rest of this entry »
When our co-founders launched the site in 2010, they wondered whether there would be enough retractions to write about on a regular basis. Five+ years and three full-time staffers later, and we simply don’t have the time to cover everything that comes across our desk.
In 2012, we covered a group of duplication retractions in a single post, simply because duplications happen so frequently (sadly) and often don’t tell an interesting story. So in the interest of bookkeeping, we’re picking up the practice again.
Here are five unrelated retractions for your perusal: all addressing duplications, in which the same – or mostly the same – authors published the same – or mostly the same – information in two different – or sometimes the same – journals.
So, on the buffet table we offer the following entrees: Read the rest of this entry »
The authors of an article about the effects of pharmaceutical drugs on the environment have retracted it before publishing the final version due to new developments in the field, which would have required a major revision.
The authors pulled the paper from Integrated Environmental Assessment and Management before it went through the final publication process – such as copyediting and proofreading – after they learned about new findings related to assessing to the risks of human exposures to pharmaceuticals in the environment.
We’d try to figure out which portions of the paper might need updating, but publisher Wiley recently pulled the original article and abstract, against the journal editor’s wishes.
The Turkish Journal of Medical Sciences has retracted a paper after concerns surfaced from a researcher who claims to have supervised the research but was not listed as a co-author.
The first author completed the research — which explored the use of epigenetic alterations as potential early signs of cancer — as part of her master’s degree, under the supervision of Muy-Teck Teh at the Barts & The London School of Medicine & Dentistry. When Teh contacted the journal to say he had not consented to the publication, Ayesha Umair claimed she had paid for the research herself.
Science magazine has issued an expression of concern for a paper on the discovery of a new immune-boosting protein. The paper’s findings, which received some press coverage when they came out last spring, are now under investigation by Imperial College London.
The expression of concern follows a correction noting a Western blot mix-up. Science Editor in Chief Marcia McNutt told us last month that the mistake resulted from “carelessness” on the part of the authors. But now, an investigation at Imperial College London — where Philip Ashton-Rickardt led the research — is formally looking into the findings.
That investigation is ongoing, according to the expression of concern (signed by McNutt):
Although many scientists fear putting their data to the test of replication efforts, due to the embarrassment they’d feel if their findings couldn’t be repeated, a new study suggests those fears are unfounded.
The paper, published last week in PLOS ONE, found that scientists overestimate how much having non-replicable data will hurt their careers, and the community values those who are honest about what went wrong.
Specifically, as the authors note:
We’re presenting a Q&A session with Peter Wilmshurst, now a part-time consultant cardiologist who has spent decades embroiled in misconduct investigations as a whistleblower.
Retraction Watch: A UK judge recently upheld two findings of dishonesty by the Medical Practitioners Tribunal Service against Andrew Dowson, director of headache services at King’s College Hospital and your former co-investigator. Were you pleased with the verdict? (Last week, Dowson also began a four-month suspension from practicing medicine in the UK.)
Peter Wilmshurst: In part, because I was pleased that he was shown to be dishonest, because I knew that he was, which was why I reported him. But I wasn’t pleased in the sense that I don’t think the investigation dealt with all the issues involved in the Migraine Intervention with STARflex Technology (MIST) Trial.
RW: What additional issues did you hope to see addressed? Read the rest of this entry »
Science is fixing images in a paper published online in April that discovered an immune-boosting protein, after the authors mistakenly mixed up similar-looking Western blots.
The paper, which received some press coverage, identified a protein that helped the immune system fight off cancers and infections. Philip Ashton-Rickardt, a scientist at Imperial College London who led the study, told the The Telegraph:
This is exciting because we have found a completely different way to use the immune system to fight cancer.
The editor in chief of Science, Marcia McNutt, told us that the journal contacted the authors once it learned of “irregularities” in some of the figures, which did not affect the conclusions of the paper: